VNDA - Vanda Pharmaceu Charts, Trade Ideas, Earnings, Ratings

TRENDING : Top 50 ARRY (-0.85%) SPY (-0.03%) XLMUSD (%) WSM (0.22%) WKHS (7.28%) VXX (-3.34%) UPST (2.36%) TLRY (3.27%) SQQQ (-1.45%) SQ (2.16%) POSH (5.09%) KOLD (5.39%) JUPW (2.14%) IBM (-0.76%) GSAT (0.74%) FUBO (7.06%) CURI (4.13%) BTCUSD (%) BOSC (0.17%) BCHUSD (%)

VNDA - Vanda Pharmaceutical...

$18.53 -0.06[-0.3%]

15 mins delayed data

People also watch :

+Watchlist

2 StockHoot Traders following this.
Analyst Ratings | Earnings

Previous Close	$18.58	Open	$18.59
Volume	51.8K	Market Cap	1.036B
Yield		Last Dividend

Day

52 Week

Shareholder Alert: Robbins LLP Announces...	03/11/21
SAN DIEGO & WASHINGTON--(BUSINESS WIRE)---- $VNDA #ClassAction--Shareholder rights law firm Robbins LLP announces that Vanda Pharmaceuticals Inc. (NAS...

The Daily Biotech Pulse: Adcom Test Awai...	02/26/21
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Feb. 25) Apy...

Vanda Pharmaceuticals Inc. (NASDAQ:VNDA)...	02/21/21
Vanda Pharmaceuticals Inc. (NASDAQ:VNDA) Director Thomas Watkins sold 5,818 shares of the firm???s stock in a transaction that occurred on Tuesday, Fe...

The Daily Biotech Pulse: European Regula...	02/12/21
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Feb. 12) 4D ...

Return On Capital Employed Overview: Van...	02/11/21
Looking at Q4, Vanda Pharmaceuticals (NASDAQ:VNDA) earned $10.45 million, a 34.99% increase from the preceding quarter. Vanda Pharmaceuticals also pos...

Recap: Vanda Pharmaceuticals Q4 Earnings	02/10/21
Shares of Vanda Pharmaceuticals (NASDAQ:VNDA) increased in after-market trading after the company reported Q4 results. Quarterly Results Earnings per ...

The Daily Biotech Pulse: Lilly COVID-19 ...	02/10/21
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Feb. 10) 9 M...

The Daily Biotech Pulse: Decision Day Fo...	01/28/21
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Jan. 27) Abb...

Vanda Pharmaceuticals Factors Likely to ...	11/02/20
Vanda Pharmaceuticals announce their quarterly, annual earnings. See the latest EPS estimates. Listen to the conference call and remind yourself by???

Vanda Pharma on go with mid-stage allerg...	10/26/20
The FDA has signed off on Vanda Pharmaceuticals' (NASDAQ:VNDA) IND for VSJ-110, a small molecule cystic fibrosis transmembrane conductance regulator (...

Vanda Pharmaceuticals Provides Update on...	08/31/20
WASHINGTON, Aug. 31, 2020 /PRNewswire/ -- Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today provided an update on its development program for tr...

Vanda Pharmaceuticals' Interim Analysis ...	08/18/20
/PRNewswire/ -- Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today reported that interim analysis showed tradipitant may accelerate clinical impr...

Shareholder Alert: Robbins LLP Is Invest...	07/21/20
SAN DIEGO & WASHINGTON--(BUSINESS WIRE)---- $VNDA #ClassAction--Shareholder rights law firm Robbins LLP announces that it is investigating the officer...

ANALYST RATINGS

1 analyst ratings (Last 3 months)

0.00 %

Strong Buy + Buy

Price Target (PT)

EARNINGS

Date	04/12/2019 (AMC)	Est. (EPS/Rev.)	$1.37
Actual (EPS/Rev.)	$2.5B	EPS (TTM)	$???

TRADERS TRACKING $VNDA

Service Name	Trader	% Success
Swing for the fences	Gino Baldassano	72.00 %	Subscribe
Alpha Swing Trades	Jonathan	68.00 %	Follow

SHOW ALL TRADERS

About Us

Get winning Stock, Option and Cryptocurrency trade ideas from pro-traders. Follow their strategies, see how they perform.

Product Types

Strategies

Follow Us

Secure Payments

We are not a registered investment advisor. All investments involve risk, individual's trading does not guarantee future results or returns. Investors are fully responsible for any investment decisions they make. References to specific securities should not be construed as a recommendation to buy or sell that security only mentioned for informational purposes.